2C-F, also known as 4-fluoro-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists the dose of 2C-F as greater than 250mg orally and its duration as unknown. At a dose of 250mg orally, 2C-F produced slight and uncertain effects including possible modest closed-eye visuals and pleasant lethargy.
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-F.
2C-F may be found as a brownish freebase oil, or as a white crystalline hydrochloride salt.
The chemical synthesis of 2C-F has been described.
Analogues of 2C-F include 2C-B, 2C-I, 2C-C, DOF, and 25F-NBOMe, among others.
2C-F was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
As of October 31, 2016, 2C-F is a controlled substance (Schedule III) in Canada.
2C-F is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.